Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS)

Lupus

Volumn 27, Issue 2, 2018, Pages 179-189

  Macedo E A ^a   Appenzeller, S ^a   Costallat, L T L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Depression; gender; systemic lupus erythematosus

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DSM-5; FEMALE; GOLD STANDARD; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY; ANXIETY; COMPLICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; SEX FACTOR; STANDARDS; UTILIZATION;

ADULT; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 85039745793     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203317713142     Document Type: Article

References (88)

1. Wallace DJ, Hahn BH. Dubois lupus erythematosus and related syndromes, 8th ed. Philadelphia: Elsevier, 2013.
2. Hanly JG. The nervous system and lupus. Systemic lupus erythematosus, 5th ed. San Diego: Elsevier, 2011, pp. 727–746.
3. Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: Pathogenesis and biomarkers. Nat Rev Neurol 2014; 10: 579–596.
4. Stojanovich L, Zandman-Goddard G, Pavlovich S, Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007; 6: 421–426.
5. Palagini L, Mosca M, Tani C, Gemignani A, Mauri M, Bombardieri S. Depression and systemic lupus erythematosus: A systematic review. Lupus 2013; 22: 409–416.
6. Lisitsyna TA, Vel’tishchev D, Seravina OF, Prevalence of mental disorders in SLE patients: Correlations with the disease activity and comorbid chronic conditions. Ter Arkh 2009; 81: 10–16.
7. Mok CC. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 2011; 20: 767–771.
8. Greco CM, Li T, Sattar A, Association between depression and vascular disease in systemic lupus erythematosus. The Journal of rheumatology 2012; 39: 262–268.
9. Xie LF, Chen PL, Pan HF, Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int 2012; 32: 2707–2714.
10. Zakeri Z, Shakiba M, Narouie B, Mladkova N, Ghasemi-Rad M, Khosravi A. Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int 2012; 32: 1179–1187.
11. Moldovan I, Cooray D, Carr F, Pain and depression predict self-reported fatigue/energy in lupus. Lupus 2013; 22: 684–689.
12. Choi ST, Kang JI, Park IH, Subscale analysis of quality of life in patients with systemic lupus erythematosus: Association with depression, fatigue, disease activity and damage. Clin Exp Rheumatol 2012; 30: 665–672.
13. Pettersson S, Lovgren M, Eriksson LE, An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol 2012; 41: 383–390.
14. Mak A, Tang CS, Ho RC. Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus. Lupus 2013; 22: 254–261.
15. Shen B, Tan W, Feng G, The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol 2013; 2013: 270878–270878.
16. Yilmaz-Oner S, Oner C, Dogukan FM, Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Exp Rheumatol 2015; 33: 360–365.
17. Petri M, Naqibuddin M, Carson KA, Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol 2010; 37: 2032–2038.
18. Cavaco S, Martins da Silva A, Santos E, Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression? J Rheumatol 2012; 39: 770–776.
19. Sibbitt WL, Jr Brandt JR, Johnson CR, The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29: 1536–1542.
20. Maneeton B, Maneeton N, Louthrenoo W. Prevalence and predictors of depression in patients with systemic lupus erythematosus: A cross-sectional study. Neuropsychiatr Dis Treat 2013; 9: 799–804.
21. Nery FG, Borba EF, Viana VS, Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Progr Neuropsychopharmacol Biol Psychiatry 2008; 32: 695–700.
22. Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 822–829.
23. Lim L, Ron MA, Ormerod IE, Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med 1988; 66: 27–38.
24. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153–163.
25. Wekking EM. Psychiatric symptoms in systemic lupus erythematosus: An update. Psychosom Med 1993; 55: 219–228.
26. Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1996; 39: 1833–1839.
27. Shortall E, Isenberg D, Newman SP. Factors associated with mood and mood disorders in SLE. Lupus 1995; 4: 272–279.
28. Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009; 36: 1449–1459.
29. Jarpa E, Babul M, Calderon J, Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 2011; 20: 58–66.
30. Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmun Rev 2015; 14: 30–35.
31. Karol DE, Criscione-Schreiber LG, Lin M, Clowse ME. Depressive symptoms and associated factors in systemic lupus erythematosus. Psychosomatics 2013; 54: 443–450.
32. Iverson GL, Sawyer DC, McCracken LM, Kozora E. Assessing depression in systemic lupus erythematosus: Determining reliable change. Lupus 2001; 10: 266–271.
33. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496–500.
34. Sanna G, Bertolaccini ML, Cuadrado MJ, Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985–992.
35. Andrade AB, Bosi MLM. Qualidade do cuidado em dois centros de atenção psicossocial sob o olhar de usuários. Saúde Soc São Paulo 2015; 24: 887–900.
36. Orive M, Padierna JA, Quintana JM, Las-Hayas C, Vrotsou K, Aguirre U. Detecting depression in medically ill patients: Comparative accuracy of four screening questionnaires and physicians’ diagnoses in Spanish population. J Psychosom Res 2010; 69: 399–406.
37. Hwang J, Lee J, Ahn JK, Park EJ, Cha HS, Koh EM. Clinical characteristics of male and female Korean patients with systemic lupus erythematosus: A comparative study. Korean J Intern Med 2015; 30: 242–249.
38. Aranow C, Del Guidice J, Barland P, Weinstein A. Systemic lupus erythematosus disease severity in men and women: A case-control study. J Rheumatol 2002; 29: 1674–1677.
39. Lu LJ, Wallace DJ, Ishimori ML, Scofield RH, Weisman MH. Review: Male systemic lupus erythematosus: A review of sex disparities in this disease. Lupus 2010; 19: 119–129.
40. Renau AI, Isenberg DA. Male versus female lupus: A comparison of ethnicity, clinical features, serology and outcome over a 30 year period. Lupus 2012; 21: 1041–1048.
41. Specker C, Becker A, Lakomek HJ, Bach D, Grabensee B. Systemic lupus erythematosus in men–a different prognosis? Z Rheumatol 1994; 53: 339–45.
42. Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 2012; 39: 759–769.
43. Macedo EA, Appenzeller S, Costallat LT. Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Lupus 2016; 25: 1315–1327.
44. Tan EM, Cohen AS, Fries JF, The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
45. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.
46. Association AP. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
47. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–571.
48. Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res 1996; 29: 453–457.
49. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.
50. Silveira DXJ, Jorge MR. Propriedades psicométricas da escala de rastreamento populacional para depressão CES-D em populações clínica e não-clínica de adolescentes e adultos jovens. Rev Psiq Clín 1998; 25: 251–261
51. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
52. Botega NJB, Bio MR, Zomignani MA, Garcia C Jr, Pereira WAB. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Pública 1995; 29: 355–363
53. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599–608
54. Beck AT, Steer AR, Garbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77–100.
55. Van Exel E, Jacobs J, Korswagen LA, Depression in systemic lupus erythematosus, dependent on or independent of severity of disease. Lupus 2013; 22: 1462–1469.
56. Lykouras E, Loannidis C, Voulgari A, Jemos J, Tzonou A. Depression among general hospital patients in Greece. Acta Psychiatr Scand 1989; 79: 148–152.
57. Hengeveld MW, Ancion FA, Rooijmans HG. Prevalence and recognition of depressive disorders in general medical inpatients. Int J Psychiatry Med 1987; 17: 341–349.
58. Judd FK, Mijch AM. Depression in patients with HIV and AIDS. Aust N Z L Psychiatry 1994; 28: 642–650.
59. Brazilian Association of Research Companies. 2014 economic classification criteria Brazil, http://www.abep.org/criterio-brasil (2014, accessed 25 December 2015)
60. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640.
61. Gladman D, Ginzler E, Goldsmith C, The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.
62. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons Inc., 1981.
63. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.
64. SAS System for Windows. 9.4 ed.: Statistical Analysis System Institute Inc., Cary, USA
65. Nanthakumar S, Bucks RS, Skinner TC. Are we overestimating the prevalence of depression in chronic illness using questionnaires? Meta-analytic evidence in obstructive sleep apnoea. Health Psychol 2016; 35: 423–432.
66. Toups M, Carmody T, Trivedi MH, Rush AJ, Hedayati SS. Performance of depression rating scales in patients with chronic kidney disease: An item response theory-based analysis. Gen Hosp Psychiatry 2016; 42: 60–66.
67. Moullec G, Plourde A, Lavoie KL, Suarthana E, Bacon SL. Beck Depression Inventory II: Determination and comparison of its diagnostic accuracy in cardiac outpatients. Eur J Prev Cardiol 2015; 22: 665–672.
68. Englbrecht M, Alten R, Aringer M, Validation of standardized questionnaires evaluating symptoms of depression in rheumatoid arthritis patients – approaches to screening for a frequent and yet underrated challenge. Arthritis Care Res 2016; 69: 58–66.
69. Fischer A, Fischer M, Nicholls RA, Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav 2015; 5: e00365–e00365.
70. Shean G, Baldwin G. Sensitivity and specificity of depression questionnaires in a college-age sample. J Genet Psychol 2008; 169: 281–288.
71. Strik JJ, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001; 42: 423–428.
72. Julian LJ, Gregorich SE, Tonner C, Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthritis Care Res 2011; 63: 884–890.
73. Terluin B, Brouwers EP, van Marwijk HW, Verhaak P, van der Horst HE. Detecting depressive and anxiety disorders in distressed patients in primary care; comparative diagnostic accuracy of the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS). BMC Fam Pract 2009; 10: 58–58.
74. Bocerean C, Dupret E. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry 2014; 14: 354–354.
75. Vallejo MA, Rivera J, Esteve-Vives J, Rodriguez-Munoz MF, Grupo I. Use of the Hospital Anxiety and Depression Scale (HADS) to evaluate anxiety and depression in fibromyalgia patients. Revista de psiquiatria y salud mental 2012; 5: 107–114.
76. Covic T, Cumming SR, Pallant JF, Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 2012; 12: 6–6.
77. Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res 2011; 63(Suppl. 11): S454–S466.
78. Santos IS, Tavares BF, Munhoz TN, Patient Health Questionnaire-9 versus Edinburgh Postnatal Depression Scale in screening for major depressive episodes: A cross-sectional population-based study. BMC Res Notes 2017; 10: 57–57.
79. Sharp R. The Hamilton Rating Scale for Depression. Occup Med 2015; 65: 340–340.
80. Bondolfi G, Jermann F, Rouget BW, Self- and clinician-rated Montgomery–Asberg Depression Rating Scale: Evaluation in clinical practice. J Affect Disord 2010; 121: 268–272.
81. Williams JW, Jr Pignone M, Ramirez G, Perez Stellato C. Identifying depression in primary care: A literature synthesis of case-finding instruments. Gen Hosp Psychiatry 2002; 24: 225–237.
82. Boyd JH, Weissman MM, Thompson WD, Myers JK. Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic scales. Arch Gen Psychiatry 1982; 39: 1195–1200.
83. Mulrow CD, Williams JW, Jr Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122: 913–921.
84. Gerety MB, Williams JW, Jr Mulrow CD, Performance of case-finding tools for depression in the nursing home: Influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc 1994; 42: 1103–1109.
85. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003; 74: 5–13.
86. Marcus SM, Young EA, Kerber KB, Gender differences in depression: Findings from the STAR*D study. J Affect Disord 2005; 87: 141–150.
87. Sloan DM, Kornstein SG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin N Am 2003; 26: 581–594.
88. Sloan DM, Sandt AR. Gender differences in depression. Women Health 2006; 2: 425–434.